Who Owns TriSalus Life Sciences Stock?
NASDAQ: TLSIHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 4.06 0.00%
Ownership breakdown
- Held by institutions
- 35.73%
- Held by insiders
- 33.96%
- Institutional holders
- 113
- Institutions 35.7%
- Insiders 34.0%
- Public and other 30.3%
Who owns TriSalus Life Sciences stock?
Institutional investors own about 35.7% of TriSalus Life Sciences's shares, spread across 113 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 33.96% of TLSI.
The largest institutional holders are First Light Asset Management, LLC (10.64%), Blackrock Inc. (4.32%) and Vanguard Capital Management LLC (2.81%). Together, the top 10 institutions control 28.1% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their TLSI positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of TLSI
| Institution | Shares | % Held | Change |
|---|---|---|---|
| First Light Asset Management, LLC | 6.55M | 10.64% | +29.3% |
| Blackrock Inc. | 2.66M | 4.32% | +77.3% |
| Vanguard Capital Management LLC | 1.73M | 2.81% | +28.4% |
| Cerity Partners LLC | 1.60M | 2.60% | +103.7% |
| Geode Capital Management, LLC | 1.19M | 1.93% | +53.1% |
| Nantahala Capital Management, LLC | 1.00M | 1.62% | -51.7% |
| Gilder Gagnon Howe & Co LLC | 850.08K | 1.38% | -4.3% |
| State Street Corporation | 610.96K | 0.99% | +86.3% |
| White Pine Capital LLC | 547.58K | 0.89% | +174.0% |
| Thompson, Siegel & Walmsley LLC | 536.53K | 0.87% | -8.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of TLSI
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.14M | 1.85% |
| iShares Trust-iShares Russell 2000 ETF | 1.10M | 1.79% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 545.76K | 0.89% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 521.75K | 0.85% |
| iShares Trust-iShares Russell 2000 Growth ETF | 453.63K | 0.74% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 235.13K | 0.38% |
| ROYCE FUND-Royce Smaller-Companies Growth Fund | 200.00K | 0.32% |
| iShares Trust-iShares Micro-Cap ETF | 162.44K | 0.26% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 143.14K | 0.23% |
| SCHWAB CAPITAL TRUST-Schwab Small-Cap Index Fund | 116.67K | 0.19% |
Frequently asked questions
Who is the largest shareholder of TriSalus Life Sciences?
First Light Asset Management, LLC is the largest institutional shareholder of TLSI, owning 10.64% of shares outstanding (6.55M shares) as of its latest 13F filing.
What percentage of TriSalus Life Sciences is owned by institutions?
Institutions own about 35.7% of TLSI shares and 54.1% of the public float.
How much of TriSalus Life Sciences do insiders own?
Insiders, such as officers and directors, own about 33.96% of TLSI shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.